newsfilter
← Latest News
GlobeNewswire·

HCW Biologics Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum

HCWB
  • HCW Biologics Inc. (NASDAQ: HCWB) adjourned its Special Meeting of Stockholders held on April 27, 2026, without conducting business due to a lack of quorum.
  • The proposals from the Special Meeting will be presented at the Company's Annual Meeting of Stockholders scheduled for June 15, 2026.
  • The Annual Meeting will be conducted virtually at 10:00 a.m. Eastern Time.
  • The Company continues to solicit votes regarding two proposals related to warrants issued to Armistice Capital Master Fund Ltd.
  • Armistice invested $17.4 million in HCW Biologics to fund clinical development programs.
  • The proposals seek approval for warrants allowing the purchase of up to 5,497,702 common shares at $0.6055 per share.
  • The Company is required to seek stockholder approval every 60 days until the proposals are approved.
  • The record date for stockholder voting eligibility was April 22, 2026.
  • HCW Biologics is a clinical-stage biopharmaceutical company developing fusion immunotherapeutics for diseases promoted by chronic inflammation.